XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Schedule of Incurred Expenses of Minority Shareholders (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Cost of Revenue $ 144,273 $ 144,273
General and Administrative Expense 3,397,613 470,278 7,731,391 1,260,371
Research and Development Expense 2,189,871 1,216,236 5,814,397 3,616,866
Total Related Party Expenses 438,890 105,702 987,897 244,447
CWRU - Royalty Fee [Member]        
Cost of Revenue 10,000 10,000
CWRU - License Agreement - Amendment Fee - Milestone III [Member]        
General and Administrative Expense 10,000 10,000
Stock-based compensation expense - Physician Inventors' restricted stock awards [Member]        
General and Administrative Expense 273,000 637,000
CWRU License Agreement - reimbursement of patent legal fees [Member]        
Research and Development Expense 82,400 79,497 195,363 138,381
EsoCheck devices provided to CWRU [Member]        
Research and Development Expense 14,941
Fees - Physician Inventors' consulting agreements [Member]        
Research and Development Expense 8,035 20,455 21,950 73,875
Stock-based compensation expense - Physician Inventors' stock options [Member]        
Research and Development Expense $ 55,455 $ 5,750 $ 113,584 $ 17,250